(NEJM, 2023) showed approximately 24% mean weight reduction with Retatrutide at 12 mg at 48 weeks, while Semaglutide demonstrated approximately 15% at 2.4 mg weekly in the STEP trials again, these are cross-trial figures drawn from studies with different designs and populations, and should be treated as indirect
But what happens if a patient cant utilize them in those dosage forms
For the same 220-pound person, 22.5% means losing roughly 50 pounds, nearly 17 more pounds than semaglutide would produce on average
Whether by diversifying your meals or turning to a multivitamin supplement, its good practice, whether youre using a GLP-1 or not, to ensure youre hitting the smaller nutritional benchmarks, tootheyre just as important
D 66 , 213221 (2010) Vagin, A
It cannot prove how one person will respond